I think you're right. There may well have been a few investors...

I think you're right. There may well have been a few investors waiting to pull the trigger, and once the run started they jumped on board, and/or it's finally happening in Germany.

This article came out four days ago on livewiremarkets.com, and given the run is on the back of a relatively small amount of shares, it could be as simple as the right deep-pocketed investors waking up to the Clinuvel story.

In between the incessant buffoonery on sharescene.com investek posted an excerpt from this article about pharmaceutical regulation in Australia. This is massive, and long overdue... a bit like the recent SP surge.

The shallow volume isn't ideal, but the fundamentals of the company are solid, so a retrace wouldn't be a huge cause for concern. I'm not selling anytime soon, so I won't be fussed if a few traders treat the stock as their plaything in the interim. In 12-24 months we'll know if we really did have shares in the best kept secret in biotech.

Hell, I've waited 13 years, I can wait a bit more.